Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

MEDP.US Logo

MEDP.US - Current Price

$599.21

Company Information

Company Name
Medpace Holdings Inc
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
ISIN: US58506Q1094
CIK: 0001668397
CUSIP: 58506Q109
Currency: USD
Full Time Employees: 6,200
Phone: 513 579 9911
Fiscal Year End: December
IPO Date: Aug 11, 2016
Description:

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Address:

5375 Medpace Way, Cincinnati, OH, United States, 45227

Directors & Officers

Name Title Year Born
Dr. August James Troendle M.D. Chairman & CEO 1956
Mr. Jesse J. Geiger BBA, CPA President 1974
Mr. Kevin M. Brady CFO & Treasurer 1974
Ms. Susan E. Burwig BSN, MA Executive Vice President of Operations 1963
Mr. Stephen P. Ewald J.D. Chief Compliance Officer, General Counsel & Corporate Secretary 1969
Mr. Brandon Ebken Chief Information Officer NA
Ms. Lauren Morris Associate Director of Investors Relations NA
Mr. Todd Meyers Vice President of Business Development & Marketing NA
Mr. Weimin Gai MS Senior Vice President of Biometrics NA
Mr. John T. Wynne MBA Senior Vice President of Commercial Operations & Clinical Pharmacology Unit NA

Shares Statistics

Shares Outstanding: 28.17M
Shares Float: 22.65M
% Insiders: 1,954.00%
% Institutions: 8,852.70%
Short % Float: 6.45%

Valuation Metrics

Enterprise Value: $16.59B
Trailing P/E: 41.49
Forward P/E: 37.31

Financial Highlights

Market Cap: $16.76B
EBITDA: $535.54M
P/E Ratio: $41.49
PEG Ratio: $3.77
Book Value: $10.27
Earnings/Share: $14.34
Profit Margin: 18.36%
Operating Margin: 21.49%
ROA (TTM): 16.52%
ROE (TTM): 73.70%
Revenue (TTM): $2.36B
Revenue/Share (TTM): $79.91
Earnings Growth (YOY): 28.20%
Revenue Growth (YOY): 23.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 4.18 N/A -10,000.00%
Sep 30, 2025 3.86 3.53 N/A 934.84%
Jun 30, 2025 3.10 2.99 N/A 377.93%
Mar 31, 2025 3.67 3.08 N/A 1,925.26%
Dec 31, 2024 3.68 3.12 N/A 1,811.53%
Sep 30, 2024 3.01 2.78 N/A 827.34%
Jun 30, 2024 2.75 2.54 N/A 826.77%
Mar 31, 2024 3.20 2.47 N/A 2,955.47%
Dec 31, 2023 2.46 2.22 N/A 1,081.08%
Sep 30, 2023 2.22 2.05 N/A 829.27%
Jun 30, 2023 1.93 1.91 N/A 104.71%
Mar 31, 2023 2.27 1.80 N/A 2,611.11%
Dec 31, 2022 2.12 1.79 N/A 1,843.58%
Sep 30, 2022 2.05 1.47 N/A 3,945.58%
Jun 30, 2022 1.46 1.31 N/A 1,145.04%
Mar 31, 2022 1.69 1.26 N/A 3,412.70%
Dec 31, 2021 1.32 1.25 N/A 560.00%
Sep 30, 2021 1.29 1.07 N/A 2,056.07%
Jun 30, 2021 1.06 0.99 N/A 707.07%
Mar 31, 2021 1.14 1.00 N/A 1,400.00%
Dec 31, 2020 1.35 1.24 N/A 887.10%
Sep 30, 2020 1.09 1.07 N/A 186.92%
Jun 30, 2020 0.68 0.41 N/A 6,585.37%
Mar 31, 2020 0.80 0.75 N/A 666.67%
Dec 31, 2019 0.85 0.75 N/A 1,333.33%
Sep 30, 2019 0.71 0.71 N/A 0.00%
Jun 30, 2019 0.81 0.64 N/A 2,656.25%
Mar 31, 2019 0.64 0.60 N/A 666.67%
Dec 31, 2018 0.76 0.67 N/A 1,343.28%
Sep 30, 2018 0.67 0.62 N/A 806.45%
Jun 30, 2018 0.61 0.42 N/A 4,523.81%
Mar 31, 2018 0.55 0.44 N/A 2,500.00%
Dec 31, 2017 0.39 0.38 N/A 263.16%
Sep 30, 2017 0.40 0.36 N/A 1,111.11%
Jun 30, 2017 0.38 0.30 N/A 2,666.67%
Mar 31, 2017 0.34 0.37 N/A -810.81%
Dec 31, 2016 0.35 0.34 N/A 294.12%
Sep 30, 2016 0.40 0.34 N/A 1,764.71%
Jun 30, 2016 0.45 0.34 N/A 3,235.29%

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $669.44M $N/A $2.10B $1.28B $825.55M
2023-12-31 $245.45M $N/A $1.66B $1.10B $558.95M
2022-12-31 $28.27M $N/A $1.35B $966.11M $386.39M
2021-12-31 $461.30M $N/A $1.66B $707.01M $952.93M
2020-12-31 $277.77M $N/A $1.39B $584.90M $805.78M
2019-12-31 $131.92M $N/A $1.14B $416.79M $726.28M
2018-12-31 $23.28M $N/A $967.93M $378.23M $589.70M
2017-12-31 $26.49M $N/A $950.72M $447.19M $503.53M
2016-12-31 $37.10M $N/A $979.11M $368.40M $610.71M
2015-12-31 $14.88M $N/A $984.04M $570.57M $413.47M
2014-12-31 $54.29M $N/A $1.10B $694.94M $401.97M
2013-12-31 $N/A $N/A $N/A $N/A $N/A

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 03, 2025 N/A N/A N/A N/A N/A N/A
Aug 29, 2025 N/A N/A N/A N/A N/A N/A
Aug 27, 2025 N/A N/A N/A N/A N/A N/A
Aug 19, 2025 N/A N/A N/A N/A N/A N/A
Aug 04, 2025 N/A N/A N/A N/A N/A N/A
Jul 28, 2025 N/A N/A N/A N/A N/A N/A
Jul 28, 2025 N/A N/A N/A N/A N/A N/A
Jul 28, 2025 N/A N/A N/A N/A N/A N/A
Jul 24, 2025 N/A N/A N/A N/A N/A N/A
Jul 24, 2025 N/A N/A N/A N/A N/A N/A
Jul 24, 2025 N/A N/A N/A N/A N/A N/A
Jul 23, 2025 N/A N/A N/A N/A N/A N/A
Jul 22, 2025 N/A N/A N/A N/A N/A N/A
Apr 24, 2025 N/A N/A N/A N/A N/A N/A
Feb 27, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist